5409002025-04-012025-06-305409002025-06-305409002025-04-012025-06-30in-capmkt:OtherExpenses1Member5409002025-04-012025-06-30in-capmkt:ReportableSegments1Member5409002025-04-012025-06-30in-capmkt:ReportableSegments2Member5409002025-04-012025-06-30in-capmkt:ReportableSegments3Member5409002025-04-012025-06-30in-capmkt:ReportableSegments4Member5409002025-04-012025-06-30in-capmkt:ReportableSegments1Member5409002025-04-012025-06-30in-capmkt:ReportableSegments2Member5409002025-04-012025-06-30in-capmkt:ReportableSegments3Member5409002025-04-012025-06-30in-capmkt:ReportableSegments4Member5409002025-04-012025-06-30in-capmkt:ReportableSegments1Member5409002025-06-30in-capmkt:ReportableSegments1Member5409002025-04-012025-06-30in-capmkt:ReportableSegments2Member5409002025-06-30in-capmkt:ReportableSegments2Member5409002025-04-012025-06-30in-capmkt:ReportableSegments3Member5409002025-06-30in-capmkt:ReportableSegments3Member5409002025-04-012025-06-30in-capmkt:ReportableSegments4Member5409002025-06-30in-capmkt:ReportableSegments4Member5409002025-04-012025-06-30in-capmkt:ReportableSegments1Member5409002025-06-30in-capmkt:ReportableSegments1Member5409002025-04-012025-06-30in-capmkt:ReportableSegments2Member5409002025-06-30in-capmkt:ReportableSegments2Member5409002025-04-012025-06-30in-capmkt:ReportableSegments3Member5409002025-06-30in-capmkt:ReportableSegments3Member5409002025-04-012025-06-30in-capmkt:ReportableSegments4Member5409002025-06-30in-capmkt:ReportableSegments4Member5409002025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15409002025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss15409002025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss2iso4217:INRiso4217:INRxbrli:shares540900NEWGENNOTLISTEDINE619B01017NEWGEN SOFTWARE TECHNOLOGIES LIMITEDMain BoardEquity2025-04-012026-03-312025-07-172025-07-11INRLakhsQuarterlyFirst quarterGeographical2025-07-1712:20:002025-07-1712:30:00Not applicable2025-04-012025-06-30UnauditedConsolidated320656300029387100035004340000001815115000122040009059400094145300028593660006410680000641068000151925000-806300014386200004972060000000497206000302280005274340004972060000302280005274340001404258000103.553.45003.553.451. The above financial results for the quarter ended 30 June 2025 were reviewed by the Audit Committee in the meeting held on 17 July 2025 and approved by the Board of Directors in their meeting held on 17 July 2025. Standalone and Consolidated financial results of the Company for the quarter ended 30 June 2025 are prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013 and relevant rules thereunder. The company has complied with the guidelines issued by Securities & Exchange Board of India (SEBI) to the extent applicable. <BR> 2. The auditors have carried out limited review of Standalone and Consolidated results of the Company for the quarter ended 30 June 2025. There are no qualifications in the Auditor's review report on these financial results. The figures for the quarter ended 31 March 2025 are the balancing figures between the audited figures for full financial year up to 31 March 2025 and the unaudited year-to-date figures up to the nine months ended 31 December 2024 which were subjected to limited review. <BR> 3. The Board of Directors in their meeting held on 2 May 2025 recommended a dividend of INR 5.00 per equity share for the financial year ended 31 March 2025. The payment is subject to approval of shareholders at the ensuing Annual General Meeting. <BR> 4. During the quarter ended 30 June 2025, the Nomination & Remuneration Committee has granted 93,300 options to its employees under Newgen ESOP Scheme 2022 on 1 May 2025. <BR> 5. Previous periods/years figures have been regrouped/reclassified wherever necessary to correspond with the current period/year classification/disclosure, which are not considered material to these financial results. <BR> Other Expenses941453000India953479000EMEA1033710000APAC499078000USA720296000320656300003206563000India101292000EMEA168193000APAC83612000USA9950900045260600012204000-200666000641068000India2559449000EMEA2723875000APAC1283520000USA201922600085860700001212358300020709653000India1169665000EMEA1157691000APAC672752000USA100749500040076030009779890004985592000Note :- <BR> a) Unallocated assets, liabilities, revenue and expenses : <BR> Certain assets, liabilities, revenue and expenses are not specifically allocable to individual segments as the underlying services are used interchangeably. The Company believes that it is not practicable to provide segment disclosures relating to such assets, liabilities, revenue and expenses and accordingly such assets, liabilities, revenue and expenses are separately disclosed as ‘unallocated’.Re-measurement gains / (losses) on defined benefit plans-2738000-2738000-957000Debt instruments through other comprehensive income - net change in fair value-1994000Exchange differences on translation of foreign operations3353800031544000-46500030228000